EUVIMED · CrossrefJournal
Clinical and Translational Science
ISSN 1752-8054 · Wiley
Latest articles
Compliance by Design: Governing AI ‐Augmented Quantitative Analysis in Clinical and Translational Research
Treprostinil: Mechanism of Action, Clinical, and Translational Science
Phase 1 Evaluation of the Pharmacokinetics of Sevasemten ( EDG ‐5506) for Potential Food Effect and Drug–Drug Interaction With a CYP3A4 Moderate Inhibitor
Defining Core Functions and Forms for the Implementation of Pharmacogenomics Testing in Primary Care
Correction to “Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension”
Application of Mechanistic Modeling to Support Dose‐Relevant Decision Making for CAR ‐T Cell Therapy in Oncology: A Systematic Scoping Review
Effect of Food on the Pharmacokinetics, Pharmacodynamics, and Safety of Zastaprazan, a Potassium‐Competitive Acid Blocker, in Healthy Participants
Design to Dose: Integrating Quantitative Insights Across the Antibody Drug Conjugate ( ADC ) Development Lifecycle
Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development
Assessing EHR Cohort Fitness With Partially Paired Registry Data: A New Statistical Approach Applied to Maternal Health in OneFlorida +
Digital Health Technologies and the Widening Universe of Clinical Trial Data: From Data to Decision
An In Silico–In Vitro Framework for Model‐Informed Precision Dosing in Oncology: Proof‐of‐Principle for Doxorubicin in Patient‐Derived Sarcoma Spheroids
Single‐Cell Transcriptomic Landscape of the Human Discoid Meniscus: Identification of Candidate Cell States and Transcriptional Programs
Nine‐Year Trends in Treatment Patterns, Comorbidities, and Healthcare Utilization in Type 2 Diabetes in France: Insights From Integrated Health Data
The Relationship Between Pre‐Operative Ipilimumab and Nivolumab Pharmacokinetics and Treatment Outcome in Locoregionally Advanced Urothelial Cancer
Will AI Make Systematic Reviews Obsolete? Living Evidence Engines and the Verification Bottleneck: A Perspective
Translational Constraints and Next‐Generation Design of IL ‐6 Pathway Biologics in Inflammatory Bowel Disease
Real‐World Claims Data on Prescribed Drugs and the Associated Drug–Drug Interaction Risk in Sickle Cell Disease in the United States
From Real World Data to Real Impact: A Co‐Medication Framework for Lung Cancer to Advance DDI Assessment and Patient‐Centric Drug Development
Issue Information
A Simulation‐Based Assessment of Dosage Regimen Appropriateness for Multiple Myeloma Medicines Reflecting Demographic and Ethnic Differences
Anti‐ PEG Antibodies From mRNA COVID ‐19 Vaccines Affect In Vitro Measurements of Pegylated Drug Levels
Liquid Chromatography–Tandem Mass Spectrometry Quantification of Diet‐Derived CYP2D6 Biomarkers for Clinical Phenotyping in Japanese Subjects
Genetic Landscape of NAT2 in the Moroccan Population: Implications for Isoniazid Pharmacogenetics in Tuberculosis
Brexanolone, a First‐In‐Class Neurosteroid Medication: Mechanism of Action, Clinical, and Translational Science
Exploring Risks of Adverse Drug Events From Single Drug to Three‐Drug Combination
Safety and Pharmacokinetics of Olamkicept Doses up to 2400 mg in Healthy Japanese Men: Phase I, Randomized, Placebo‐Controlled, and Double‐Blind Trial
Tutorial on Analyzing Patient‐Reported Outcome Measures in Clinical Development
Evaluation of a Novel Peptide‐Based ELISA for the Serological Diagnosis of Trypanosoma cruzi Infection
Metoprolol Population Pharmacokinetics in Older Chinese Patients With CKM Syndrome: Joint Effects of rs1065852 and CKM 2 S 2 ‐ BAG Score on Clearance
EUVIMED